RecruitingNCT06605469

Ejaculatory and Orgasmic Dysfunction Registry

Ejaculatory and Orgasmic Dysfunction Registry (Climax Registry)

Sponsor

Charitable Union for the Research and Education of Peyronie's Disease

Enrollment

500 participants

Start Date

May 30, 2024

Study Type

OBSERVATIONAL

Conditions

Premature Ejaculation Delayed Ejaculation Anorgasmia Ejaculatory Dysfunction Anejaculation Dysejaculation Dysorgasmia

Summary

The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with anejaculation, anorgasmia, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.